{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"81.8"},{"groupId":"OG001","value":"81.1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"77"},{"groupId":"OG001","value":"37"}],"units":"Participants"}],"description":"Comparability of the graft durability between the BL-8040 + G-CSF arm and the placebo + G-CSF arm at 12 months post transplantation","groups":[{"description":"Part 2: Randomized, double-blind, placebo-controlled period","id":"OG000","title":"BL-8040 + G-CSF Part 2"},{"description":"Part 2: Randomized, double-blind, placebo-controlled period","id":"OG001","title":"Placebo + G-CSF Part 2"}],"paramType":"NUMBER","populationDescription":"Post Transplantation Analysis Set (all randomized subjects treated, with at least 1 apheresis session, and who underwent transplantation).\n\nGraft durability was not assessed during Part 1 of the study.","reportingStatus":"POSTED","timeFrame":"12 Month Post Transplantation","title":"Graft Durability at 12 Months Post Transplantation","type":"SECONDARY","unitOfMeasure":"Percentage of responders"}